Log In
Print
BCIQ
Print
Print this Print this
 

CS-4771

  Manage Alerts
Collapse Summary General Information
Company Daiichi Sankyo Co. Ltd.
DescriptionToll-like receptor 4 (TLR4) inhibitor
Molecular Target Toll-like receptor 4 (TLR4)
Mechanism of ActionToll-like receptor 4 (TLR4) inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationSepsis
Indication DetailsTreat sepsis
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today